Shigeru Takeshita

Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614

Hideaki Minoura, Shigeru Takeshita, Makoto Ita et al. · European Journal of Pharmacology · 2004 · 80 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Clinical profile of gilteritinib in Japanese patients with relapsed/refractory acute myeloid leukemia: An open‐label phase 1 study

Kensuke Usuki, Toru Sakura, Yukio Kobayashi et al. · Cancer Science · 2018 · 62 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin–mimetic vanadyl complex: Bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S2O2) coordination mode

Shigeru Takeshita, Ikuo Kawamura, Tohru Yasuno et al. · Journal of Inorganic Biochemistry · 2001 · 55 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor γ agonist, on insulin resistance in Zucker fatty rat

Hideaki Minoura, Shigeru Takeshita, Tadashi Yamamoto et al. · European Journal of Pharmacology · 2005 · 34 citations

Medicine, Endocrinology, Pharmacology +14

Diabetic modifier QTLs identified in F2 intercrosses between Akita and A/J mice

Shigeru Takeshita, Maki Moritani, Kiyoshi Kunika et al. · Mammalian Genome · 2006 · 25 citations

Medicine, Genetics, Molecular Genetics +11